Back

Considerations on clinical implications

31 August 2025 (15:46 - 15:54)
Organised by: Logo
Congress Presentation Part of: A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function Treatment Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Stephan Rosenkranz

Heart Center at the University of Cologne, Cologne (Germany)

5 More presentations in this session

Presentation thumbnail
Welcome
Presentation thumbnail
Right ventricular (RV) function assessment in PAH: why do we care?
Professor V. Moles (Ann Arbor, US)
Presentation thumbnail
A new pathway to treat PAH targeted by the first activin signaling inhibitor (ASI)
Doctor M. Escribano Subias (Madrid, ES)
Presentation thumbnail
Clinical data into context: effect of sotatercept on right ventricular (RV) function and structure
Doctor A. Vaidya (Temple, US)
Presentation thumbnail
Q&A
Professor S. Rosenkranz (Cologne, DE)

Access the full session

Session thumbnail
A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 15:46 CET
You may be interested in
thumbnail
Congress Session
From bench to bedside: how changes in the data landscape have shaped venous thromboembolism treatment as well as prevention of recurrence
26 August 2023
thumbnail
ESC TV Today
Episode 17: Coronary sinus reducer - Best strategies to reach LDL cholesterol goals
5 June 2025
thumbnail
Congress Session
Reducing hospitalisations and improving quality of life: why use cardiac contractility modulation (CCM)?
20 May 2023
thumbnail
Congress Session
What matters to me? Optimising adherence and patient outcomes in secondary prevention
13 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources